Caffeine counteracts impairments in task-oriented psychomotor performance induced by chlorpheniramine: A double-blind placebo-controlled crossover study

Journal of Psychopharmacology

Volumn 27, Issue 1, 2013, Pages 62-70

  Kim, Sung Wan ^a   Bae, Kyung Yeol ^a   Shin, Hee Young ^a,b   Kim, Jae Min ^a   Shin, Il Seon ^a   Kim, Jong Keun ^a,b   Kang, Gaeun ^b   Yoon, Jin Sang ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

antihistamine; Caffeine; chlorpheniramine; psychomotor

Indexed keywords

CAFFEINE; CHLORPHENIRAMINE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; RESPONSE TIME; SOMNOLENCE; VISUAL ANALOG SCALE;

ADULT; CAFFEINE; CHLORPHENIRAMINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 84871582015     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112450784     Document Type: Article

References (59)

1. Azcona O, Barbanoj MJ, Torrent J, et al. Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol. 1995 ; 40: 393-400
2. Blanchard J, Sawers SJ. The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol. 1983 ; 24: 93-98
3. Boyle J, Eriksson M, Stanley N, et al. Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Curr Med Res Opin. 2006 ; 22: 1343-1351
4. Brice C, Smith AP. The effects of caffeine on simulated driving, subjective alertness and sustained attention. Hum Psychopharmacol. 2001 ; 16: 523-531
5. Cimbura G, Lucas DM, Bennett RC, et al. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. J Forensic Sci. 1982 ; 27: 855-867
6. Drake CL, Roehrs T, Turner L, et al. Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psychomotor performance. Neuropsychopharmacology. 2003 ; 28: 371-378
7. Gevins A, Smith ME, McEvoy LK. Tracking the cognitive pharmacodynamics of psychoactive substances with combinations of behavioral and neurophysiological measures. Neuropsychopharmacology. 2002 ; 26: 27-39
8. Hahn HM, Yum TH, Shin YW, et al. Standardization study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc. 1986 ; 25: 487-502
9. Hasenfratz M, Bunge A, Dal Pra G, et al. Antagonistic effects of caffeine and alcohol on mental performance parameters. Pharmacol Biochem Behav. 1993 ; 46: 463-465
10. Hewlett P, Smith A. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses. Hum Psychopharmacol. 2007 ; 22: 339-350
11. Hindmarch I. Critical flicker fusion frequency (CFF): the effects of psychotropic compounds. Pharmacopsychiatrica. 1982 ; 15: S44 - S48
12. Hindmarch I, Parrott AC. Repeated dose comparison of nomifensine, imipramine and placebo on subjective assessments of sleep and objective measures of psychomotor performance. Br J Clin Pharmacol. 1977 ; 4: S167 - S173
13. Hindmarch I, Subhan S, Stoker MJ. The effects of simeldine and amitriptyline on car driving and psychomotor performance. Acta Psychiatr Scand. 1983 ; 68: 141-146
14. Hindmarch I, Trick L, Ridout F. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology. 2005 ; 183: 133-143
15. James JE, Rogers PJ. Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation. Psychopharmacology. 2005 ; 182: 1-8
16. Johnson LC, Spinweber CL, Gomez SA. Benzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood. Psychopharmacology. 1990 ; 101: 160-167
17. Kamimori GH, Penetar DM, Headley DB, et al. Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. Eur J Clin Pharmacol. 2000 ; 56: 537-544
18. Kaplan GB, Greenblatt DJ, Ehrenberg BL, et al. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997 ; 37: 693-703
19. Kelemen WL, Creeley CE. Caffeine (4 mg/kg) influences sustained attention and delayed free recall but not memory predictions. Hum Psychopharmacol. 2001 ; 16: 309-319
20. Kerr JS, Sherwood N, Hindmarch I. Separate and combined effects of the social drugs on psychomotor performance. Psychopharmacology. 1991 ; 104: 113-119
21. Kim SW, Bae KY, Shin HY, et al. The role of acetaldehyde in human psychomotor function: a double-blind placebo-controlled crossover study. Biol Psychiatry. 2010 ; 67: 840-845
22. Lee SY, Sohn KM, Ryu JY, et al. Sequence-based CYP2D6 genotyping in the Korean population. Ther Drug Monit. 2006 ; 28: 382-327
23. Liguori A, Robinson JH. Caffeine antagonism of alcoholinduced driving impairment. Drug Alcohol Depend. 2001 ; 63: 123-129
24. Lorist MM, Snel J. Caffeine effects on perceptual and motor processes. Electroenceph Clin Neurophysiol. 1997 ; 102: 401-413
25. Lorist MM, Snel J, Kok A, et al. Influence of caffeine on selective attention in well rested and fatigued subjects. Psychophysiol. 1994 ; 31: 525-534
26. Mandel HG. Update on caffeine consumption, disposition and action. Food Chem Toxicol. 2002 ; 40: 1231-1234
27. Mochizuki H, Tashiro M, Tagawa M, et al. The effects of a sedative antihistamine, D-chlorpheniramine, on visuomotor spatial discrimination and regional brain activity as measured by positron emission tomography (PET). Hum Psychopharmacol. 2002 ; 17: 413-418
28. Nehlig A. Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev. 1999 ; 23: 563-576
29. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev. 1992 ; 17: 139-170
30. Peets EA, Jackson M, Symchowicz S. Metabolism of chlorpheniramine maleate in man. J Pharmacol Exp Ther. 1972 ; 180: 364-374
31. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005 ; 7: 102-109
32. Pollack AE, Fink JS. Adenosine antagonists potentiate D2 dopamine dependent activation of fos in the striatopallidal pathway. Neuroscience. 1995 ; 68: 721-728
33. Riccio CA, Waldrop JJ, Reynolds CR, et al. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci. 2001 ; 13: 326-335
34. Ridout F, Hindmarch I. Effects of tianeptine and mianserin on car driving skills. Psychopharmacology. 2001 ; 154: 356-361
35. Ridout F, Meadows R, Johnsen S, et al. A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance. Hum Psychopharmacol. 2003 ; 18: 261-269
36. Roache JD, Griffiths RR. Interactions of diazepam and caffeine: behavioral and subjective dose effects in humans. Pharmacol Biochem Behav. 1987 ; 26: 801-812
37. Robertson D, Frölich JC, Carr RK, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978 ; 298: 181-186
38. Saunders JB, Aasland OG, Babor TF, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 1993 ; 88: 791-804
39. Sen A, Akin A, Craft KJ, et al. First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005. Aviat Space Environ Med. 2007 ; 78: 514-522
40. Serra-Grabulosa JM, Adan A, Falcón C, et al. Glucose and caffeine effects on sustained attention: an exploratory fMRI study. Hum Psychopharmacol. 2010 ; 25: 543-552
41. Shamsi Z, Kimber S, Hindmarch I. an investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol. 2001 ; 56: 865-871
42. Skegg DC, Richards SM, Doll R. Minor tranquillisers and road accidents. Br Med J. 1979 ; 1: 917-919
43. Smith A. Effects of caffeine on human behavior. Food Chem Toxicol. 2002 ; 40: 1243-1255
44. Smith A, Brice C, Nash J, et al. Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function. J Psychopharmacol. 2003 ; 17: 283-292
45. Smith A, Sutherland D, Christopher G. Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers. J Psychopharmacol. 2005 ; 19: 620-626
46. Snyder SH, Sklar P. Behavioral and molecular actions of caffeine: focus on adenosine. J Psychiatr Res. 1984 ; 18: 91-106
47. Tashiro M, Horikawa E, Mochizuki H, et al. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. Hum Psychopharmacol. 2005 ; 20: 501-509
48. Tashiro M, Sakurada Y, Mochizuki H, et al. Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving. Hum Psychopharmacol. 2008 ; 23: 139-150
49. Terry P, Doumas M, Desai RI, et al. Dissociations between motor timing, motor coordination, and time perception after the administration of alcohol or caffeine. Psychopharmacology. 2009 ; 202: 719-729
50. Van Ruitenbeek P, Vermeeren A, Riedel W. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. J Psychopharmacol. 2008 ; 22: 663-672
51. Vermeeren A, O'Hanlon JF. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol. 1998 ; 101: 306-311
52. Verster JC, Volkerts ER. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol. 2004 ; 92: 294-303
53. Wechsler D A Manual for the Wechsler Adult Intelligence Scale. New York: Psychological Corporation ; 1981 :
54. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000 ; 132: 354-363
55. Witek TJ, Canestrari DA, Miller RD, et al. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists. Ann Allergy Asthma Immunol. 1995 ; 74: 419-426
56. Woratanarat P, Ingsathit A, Suriyawongpaisal P, et al. Alcohol, illicit and non-illicit psychoactive drug use and road traffic injury in Thailand: a case-control study. Accid Anal Prev. 2009 ; 41: 651-657
57. Wu MN, Ho K, Crocker A, et al. The effects of caffeine on sleep in Drosophila require PKA activity, but not the adenosine receptor. J Neurosci. 2009 ; 29: 11029-11037
58. Yoon JS, Shin SM, Kook SH, et al. A preliminary study on the Korean translation of composite scale (KtCS) to measure morningness-eveningness. J Korean Neuropsychiatr Assoc. 1997 ; 36: 122-134
59. Yum TH, Park YS, Oh KJ, et al The Manual of Korean-Wechsler Adult Intelligence Scale. Seoul: Korean Guidance Press ; 1992 :